ARCHIVES

Phase III Cyramza Trial Meets OS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NIH Seeking More Women, Minorities On Committees

November 9, 1979

Drug pricing: Amgen’s “bundling” violates antitrust laws, J&J claims in suit.

October 14, 2005

New Jersey Commission Calls For Major Hike In Cancer Spending

September 25, 1987

ACS Challenged To Clarify Position On FDA Reform

March 1, 1996

Immunology Grant, Contract Coordination Set; Advice To Applicants-See New Plan

February 8, 1974

DCE Concepts Approved

March 7, 1986